Ligand functionalized substrates with enhanced binding capacity
US-9958364-B2 · May 1, 2018 · US
US10352835B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10352835-B2 |
| Application number | US-201815936767-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2018 |
| Priority date | Oct 3, 2013 |
| Publication date | Jul 16, 2019 |
| Grant date | Jul 16, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An article that can be used for biomaterial capture comprises (a) a porous substrate; and (b) borne on the porous substrate, a polymer comprising interpolymerized units of at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to the monovalent groups so as to link at least one ethylenically unsaturated group and at least one ligand functional group by a chain of at least six catenated atoms.
Opening claim text (preview).
We claim: 1. An article for biomaterial capture comprising (a) a porous substrate; and (b) grafted on said porous substrate, a polymer comprising interpolymerized units of at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to said monovalent groups so as to link at least one said ethylenically unsaturated group and at least one said ligand functional group by a chain of at least six catenated atoms (c) wherein said monomer is of the formula: CH 2 ═CR 1 —C(═O)—X—R 2 —[Z—R 2 ] n -L wherein R 1 is selected from hydrogen, alkyl, cycloalkyl, aryl, and combinations thereof; each R 2 is independently selected from hydrocarbylene, heterohydrocarbylene, and combinations thereof; X is —O— or —NR 3 —, where R 3 is selected from hydrogen, hydrocarbyl, heterohydrocarbyl, and combinations thereof; Z is heterohydrocarbylene comprising at least one hydrogen bond donor, at least one hydrogen bond acceptor, or a combination thereof; n is 1; and L is a heteroatom-containing group comprising at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof. 2. The article of claim 1 , wherein said porous substrate is a porous membrane; and/or wherein said porous substrate is polymeric. 3. The article of claim 1 wherein said monovalent ethylenically unsaturated group is selected from ethenyl, 1-alkylethenyl, and combinations thereof. 4. The article of claim 1 or any other of the preceding claims, wherein said monovalent ligand functional group is selected from carboxy, phosphono, phosphato, sulfono, sulfato, boronato, tertiary amino, quaternary amino, and combinations thereof. 5. The article of claim 1 or any other of the preceding claims, wherein said multivalent spacer group is a catenated heteroatom-containing hydrocarbon group. 6. The article of claim 5 , wherein said hydrogen bonding moiety is selected from carbonylimino, thiocarbonylimino, iminocarbonylimino, iminothiocarbonylimino, oxycarbonylimino, oxythiocarbonylimino, and combinations thereof. 7. The article of claim 1 wherein said chain has at least seven catenated atoms. 8. The article of claim 1 wherein said chain has no more than 50 catenated atoms. 9. The article of claim 1 wherein said chain has from 8 to 16 catenated atoms. 10. The article of claim 1 wherein said polymer is grafted to said porous substrate. 11. A process for preparing an article for biomaterial capture comprising (a) providing a porous substrate; and (b) grafting said porous substrate with a polymer comprising interpolymerized units of at least one monomer of the formula: CH 2 ═CR 1 —C(═O)—X—R 2 —[Z—R 2 ] n -L wherein R 1 is selected from hydrogen, alkyl, cycloalkyl, aryl, and combinations thereof; each R 2 is independently selected from hydrocarbylene, heterohydrocarbylene, and combinations thereof; X is —O— or —NR 3 —, where R 3 is selected from hydrogen, hydrocarbyl, heterohydrocarbyl, and combinations thereof; Z is heterohydrocarbylene comprising at least one hydrogen bond donor, at least one hydrogen bond acceptor, or a combination thereof; n is 1; and L is a heteroatom-containing group comprising at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof.
Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group · CPC title
Polyamides, e.g. polyester-amides · CPC title
Membrane materials having positively charged functional groups · CPC title
Graft polymerization · CPC title
using wave energy or particle radiation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.